Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2025-12-25 @ 1:32 AM
NCT ID:
NCT02317094
Eligibility Criteria:
Inclusion Criteria:
Clinical features
* Duration of weakness \> 12 months
* Weakness of finger flexors \> shoulder abductors AND knee extension \> hip flexion
Pathologic features
* Invasion of nonnecrotic fibres of mononuclear cells or rimmed vacuoles or
* increased major histocompatibility complex I (MHC-1) but no intracellular amyloid deposits or 15-18nm filaments
Exclusion Criteria:
* Lack of gait function
* Co-morbidity contraindicating the use of blood-flow restricted training (previous deep vein thrombosis/pulmonary embolism or known peripheral ischemic disease).
* Co-morbidity preventing resistance training (severe heart/lung-disease, uncontrolled hypertension (systolic \> 160mmHg, diastolic \> 100mmHg), severe knee/hip arthritis)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
35 Years
Study:
NCT02317094
Study Brief:
Protocol Section:
NCT02317094